RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Secular trends in patent ductus arteriosus management in infants born preterm in the national institute of child health and human development neonatal research network
Kaluarachchi, D. C., Rysavy, M. A., Carper, B. A., Chock, V. Y., Laughon, M. M., Backes, C. H., Colaizy, T. T., Bell, E. F., & Mcnamara, P. J. (2024). Secular trends in patent ductus arteriosus management in infants born preterm in the national institute of child health and human development neonatal research network. Journal of Pediatrics, 266, Article 113877. https://doi.org/10.1016/j.jpeds.2023.113877
We evaluated changes in patent ductus arteriosus (PDA) diagnosis and treatment from 2012 through 2021 in a network of US academic hospitals. PDA treatment decreased among infants born at 26-28 weeks but not among infants born at 22-25 weeks. Rates of indomethacin use and PDA ligation decreased while acetaminophen use and transcatheter PDA closure increased.